Publication · 2017 · NATURE BME
High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruption
Xiaoyun Ding, Martin P. Stewart, Armon Sharei, James C. Weaver, Robert S. Langer & Klavs F. Jensen
- Cells
- Cancer Cell Lines
- Cargos
- Polymers, mRNA, Protein, Antibody, DNA
Publication text
Portal does not host the full text of this publication. The summary on this page and the external publication are the available sources.
Some publications reference SQZ Biotechnologies, a company Dr. Armon Sharei and colleagues previously founded. Portal is the next generation company leveraging Dr. Sharei's platform technology.
# High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruption
This page is a text version of a Portal Biotechnologies publication. The bibliographic record is labeled in the text so it can be read without the surrounding website.
## Bibliographic record
- Title: High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruption
- Document type: Publication
- Year: 2017
- Outlet: NATURE BME
- Cells: Cancer Cell Lines
- Cargos: Polymers, mRNA, Protein, Antibody, DNA
- Page URL: https://portal.bio/publications/2017-high-throughput-nuclear-delivery-and-rapid-expression-of-dna-via-mechanical-and-elect--ajkHMREAACwAc-Dh
- Markdown URL: https://portal.bio/publications/2017-high-throughput-nuclear-delivery-and-rapid-expression-of-dna-via-mechanical-and-elect--ajkHMREAACwAc-Dh.md
- External publication: https://www.nature.com/articles/s41551-017-0039
## Summary
Xiaoyun Ding, Martin P. Stewart, Armon Sharei, James C. Weaver, Robert S. Langer & Klavs F. Jensen
## Publication text
Portal does not host the full text of this publication. The summary on this page and the external publication are the available sources.
## Provenance
Some publications reference SQZ Biotechnologies, a company Dr. Armon Sharei and colleagues previously founded. Portal is the next generation company leveraging Dr. Sharei's platform technology.
